{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:36:31Z","timestamp":1770748591468,"version":"3.50.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86951-7","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T16:53:21Z","timestamp":1737737601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of core biomarkers for tuberculosis progression through bioinformatics analysis and in vitro research"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhanpeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuihua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"86951_CR1","unstructured":"Organization, W. H. Global tuberculosis report 2023 (2023). https:\/\/www.who.int\/publications\/i\/item\/9789240083851"},{"key":"86951_CR2","doi-asserted-by":"publisher","unstructured":"Furin, J., Cox, H. & Pai, M. Tuberculosis. Lancet, 393(10181): 1642\u20131656. https:\/\/doi.org\/10.1016\/s0140-6736(19)30308-3 (2019).","DOI":"10.1016\/s0140-6736(19)30308-3"},{"key":"86951_CR3","doi-asserted-by":"publisher","unstructured":"Mirzayev, F. et al. World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update. Eur. Respir J. 57 (6). https:\/\/doi.org\/10.1183\/13993003.03300-2020 (2021).","DOI":"10.1183\/13993003.03300-2020"},{"issue":"4","key":"86951_CR4","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/med.21779","volume":"41","author":"A Bahuguna","year":"2021","unstructured":"Bahuguna, A., Rawat, S. & Rawat, D. S. QcrB in Mycobacterium tuberculosis: the new drug target of antitubercular agents. Med. Res. Rev. 41 (4), 2565\u20132581. https:\/\/doi.org\/10.1002\/med.21779 (2021).","journal-title":"Med. Res. Rev."},{"key":"86951_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(17)30079-6","author":"K Dheda","year":"2017","unstructured":"Dheda, K. et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. https:\/\/doi.org\/10.1016\/s2213-2600(17)30079-6 (2017).","journal-title":"Lancet Respir Med."},{"key":"86951_CR6","doi-asserted-by":"publisher","unstructured":"Dookie, N. et al. The changing paradigm of drug-resistant tuberculosis treatment: successes, pitfalls, and future perspectives. Clin. Microbiol. Rev. 35 (4). https:\/\/doi.org\/10.1128\/cmr.00180-19 (2022). e0018019.","DOI":"10.1128\/cmr.00180-19"},{"issue":"6","key":"86951_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10529-017-2319-0","volume":"39","author":"\u00c1 Dom\u00ednguez","year":"2017","unstructured":"Dom\u00ednguez, \u00c1. et al. Transcriptomics as a tool to discover new antibacterial targets. Biotechnol. Lett. 39 (6), 819\u2013828. https:\/\/doi.org\/10.1007\/s10529-017-2319-0 (2017).","journal-title":"Biotechnol. Lett."},{"issue":"5","key":"86951_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2217\/bmm.15.16","volume":"9","author":"IC van Rensburg","year":"2015","unstructured":"van Rensburg, I. C. & Loxton, A. G. Transcriptomics: the key to biomarker discovery during tuberculosis? Biomark. Med. 9 (5), 483\u2013495. https:\/\/doi.org\/10.2217\/bmm.15.16 (2015).","journal-title":"Biomark. Med."},{"issue":"2","key":"86951_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00203-017-1448-0","volume":"200","author":"C Putim","year":"2018","unstructured":"Putim, C. et al. Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis. Arch. Microbiol. 200 (2), 299\u2013309. https:\/\/doi.org\/10.1007\/s00203-017-1448-0 (2018).","journal-title":"Arch. Microbiol."},{"issue":"1","key":"86951_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.13116","volume":"309","author":"M Kaforou","year":"2022","unstructured":"Kaforou, M. et al. Transcriptomics for child and adolescent tuberculosis. Immunol. Rev. 309 (1), 97\u2013122. https:\/\/doi.org\/10.1111\/imr.13116 (2022).","journal-title":"Immunol. Rev."},{"key":"86951_CR11","doi-asserted-by":"publisher","unstructured":"Popov, D., Jain, L., Alhilali, M., Dalbeth, N. & Poulsen, R. C. Monosodium urate crystals alter the circadian clock in macrophages leading to loss of NLRP3 inflammasome repression: implications for timing of the gout flare. Faseb J. 37 (6). https:\/\/doi.org\/10.1096\/fj.202202035R (2023). e22940.","DOI":"10.1096\/fj.202202035R"},{"key":"86951_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ejmech.2018.03.020","volume":"150","author":"A Campani\u00e7o","year":"2018","unstructured":"Campani\u00e7o, A., Moreira, R. & Lopes, F. Drug discovery in tuberculosis. New drug targets and antimycobacterial agents. Eur. J. Med. Chem. 150, 525\u2013545. https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.020 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"86951_CR13","doi-asserted-by":"publisher","first-page":"660916","DOI":"10.3389\/fimmu.2021.660916","volume":"12","author":"S Krug","year":"2021","unstructured":"Krug, S., Parveen, S. & Bishai, W. R. Host-directed therapies: modulating inflammation to treat tuberculosis. Front. Immunol. 12, 660916. https:\/\/doi.org\/10.3389\/fimmu.2021.660916 (2021).","journal-title":"Front. Immunol."},{"key":"86951_CR14","doi-asserted-by":"crossref","unstructured":"Udinia, S., Suar, M., Kumar, D. Host-directed therapy against tuberculosis: concept and recent developments. J. Biosci. 48, 54 (2023).","DOI":"10.1007\/s12038-023-00374-y"},{"issue":"3","key":"86951_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1006\/bbrc.2000.3743","volume":"277","author":"P Matos","year":"2000","unstructured":"Matos, P. et al. Small GTPase Rac1: structure, localization, and expression of the human gene. Biochem. Biophys. Res. Commun. 277 (3), 741\u2013751. https:\/\/doi.org\/10.1006\/bbrc.2000.3743 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"86951_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2023.01.009","volume":"183","author":"GC Lodde","year":"2023","unstructured":"Lodde, G. C. et al. Characterisation and outcome of RAC1 mutated melanoma. Eur. J. Cancer. 183, 1\u201310. https:\/\/doi.org\/10.1016\/j.ejca.2023.01.009 (2023).","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"86951_CR17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000453454","volume":"9","author":"N Alaridah","year":"2017","unstructured":"Alaridah, N. et al. Mycobacteria manipulate G-Protein-coupled receptors to increase mucosal Rac1 expression in the lungs. J. Innate Immun. 9 (3), 318\u2013329. https:\/\/doi.org\/10.1159\/000453454 (2017).","journal-title":"J. Innate Immun."},{"issue":"3","key":"86951_CR18","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1158\/0008-5472.Can-12-1882","volume":"73","author":"G Redelman-Sidi","year":"2013","unstructured":"Redelman-Sidi, G., Iyer, G., Solit, D. B. & Glickman, M. S. Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells. Cancer Res. 73 (3), 1156\u20131167. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-1882 (2013).","journal-title":"Cancer Res."},{"issue":"5","key":"86951_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/gb-2007-8-5-215","volume":"8","author":"Y Takada","year":"2007","unstructured":"Takada, Y., Ye, X. & Simon, S. The integrins. Genome Biol. 8 (5), 215. https:\/\/doi.org\/10.1186\/gb-2007-8-5-215 (2007).","journal-title":"Genome Biol."},{"issue":"4","key":"86951_CR20","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1159\/000495683","volume":"51","author":"Y Wu","year":"2018","unstructured":"Wu, Y. et al. Mycobacterial infection is promoted by neutral sphingomyelinase 2 regulating a signaling cascade leading to activation of \u03b21-Integrin. Cell. Physiol. Biochem. 51 (4), 1815\u20131829. https:\/\/doi.org\/10.1159\/000495683 (2018).","journal-title":"Cell. Physiol. Biochem."},{"key":"86951_CR21","doi-asserted-by":"publisher","first-page":"836797","DOI":"10.3389\/fcell.2022.836797","volume":"10","author":"CM Borza","year":"2022","unstructured":"Borza, C. M. et al. The collagen receptor discoidin domain receptor 1b enhances integrin \u03b21-mediated cell migration by interacting with talin and promoting Rac1 activation. Front. Cell. Dev. Biol. 10, 836797. https:\/\/doi.org\/10.3389\/fcell.2022.836797 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"key":"86951_CR22","doi-asserted-by":"publisher","unstructured":"Sun, J. et al. Mycobacterium tuberculosis Nucleoside diphosphate kinase inactivates small GTPases leading to evasion of innate immunity. PLoS Pathog. 9 (7). https:\/\/doi.org\/10.1371\/journal.ppat.1003499 (2013). e1003499.","DOI":"10.1371\/journal.ppat.1003499"},{"key":"86951_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2021.07.019","volume":"480","author":"P Sarvari","year":"2021","unstructured":"Sarvari, P. et al. The E3 ubiquitin-protein ligase Rbx1 regulates cardiac wall morphogenesis in zebrafish. Dev. Biol. 480, 1\u201312. https:\/\/doi.org\/10.1016\/j.ydbio.2021.07.019 (2021).","journal-title":"Dev. Biol."},{"issue":"4","key":"86951_CR24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10120-013-0318-y","volume":"17","author":"K Migita","year":"2014","unstructured":"Migita, K. et al. Prognostic impact of RING box protein-1 (RBX1) expression in gastric cancer. Gastr. Cancer. 17 (4), 601\u2013609. https:\/\/doi.org\/10.1007\/s10120-013-0318-y (2014).","journal-title":"Gastr. Cancer"},{"issue":"31","key":"86951_CR25","doi-asserted-by":"publisher","first-page":"E4272","DOI":"10.1073\/pnas.1423449112","volume":"112","author":"JA Awuh","year":"2015","unstructured":"Awuh, J. A. et al. Keap1 regulates inflammatory signaling in Mycobacterium avium-infected human macrophages. Proc. Natl. Acad. Sci. U S A. 112 (31), E4272\u2013E4280. https:\/\/doi.org\/10.1073\/pnas.1423449112 (2015).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"86951_CR26","doi-asserted-by":"publisher","unstructured":"Mena, E. L. et al. ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection. Proc. Natl. Acad. Sci. U S A. 118 (17). https:\/\/doi.org\/10.1073\/pnas.2023157118 (2021).","DOI":"10.1073\/pnas.2023157118"},{"key":"86951_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-micro-041020-025803","volume":"76","author":"R Mukherjee","year":"2022","unstructured":"Mukherjee, R. & Dikic, I. Regulation of host-pathogen interactions via the ubiquitin system. Annu. Rev. Microbiol. 76, 211\u2013233. https:\/\/doi.org\/10.1146\/annurev-micro-041020-025803 (2022).","journal-title":"Annu. Rev. Microbiol."},{"issue":"Pt 21","key":"86951_CR28","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1242\/jcs.111.21.3145","volume":"111","author":"U Atasoy","year":"1998","unstructured":"Atasoy, U., Watson, J., Patel, D. & Keene, J. D. ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J. Cell. Sci. 111 (Pt 21), 3145\u20133156. https:\/\/doi.org\/10.1242\/jcs.111.21.3145 (1998).","journal-title":"J. Cell. Sci."},{"issue":"4","key":"86951_CR29","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.4049\/jimmunol.176.4.2105","volume":"176","author":"JG Wang","year":"2006","unstructured":"Wang, J. G. et al. LFA-1-dependent HuR nuclear export and cytokine mRNA stabilization in T cell activation. J. Immunol. 176 (4), 2105\u20132113. https:\/\/doi.org\/10.4049\/jimmunol.176.4.2105 (2006).","journal-title":"J. Immunol."},{"issue":"11","key":"86951_CR30","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.4049\/jimmunol.0900377","volume":"182","author":"O Papadaki","year":"2009","unstructured":"Papadaki, O. et al. Control of thymic T cell maturation, deletion and egress by the RNA-binding protein HuR. J. Immunol. 182 (11), 6779\u20136788. https:\/\/doi.org\/10.4049\/jimmunol.0900377 (2009).","journal-title":"J. Immunol."},{"key":"86951_CR31","doi-asserted-by":"publisher","first-page":"108671","DOI":"10.1016\/j.fsi.2023.108671","volume":"135","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y., Chen, L. & Ni, S. Identification and functional characterization of zebrafish ELAVL1b as a new member of antimicrobial protein. Fish. Shellfish Immunol. 135, 108671. https:\/\/doi.org\/10.1016\/j.fsi.2023.108671 (2023).","journal-title":"Fish. Shellfish Immunol."},{"issue":"1","key":"86951_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/onc.2017.314","volume":"37","author":"L Liu","year":"2018","unstructured":"Liu, L. et al. MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression. Oncogene 37 (1), 86\u201394. https:\/\/doi.org\/10.1038\/onc.2017.314 (2018).","journal-title":"Oncogene"},{"issue":"1","key":"86951_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2020.11.001","volume":"54","author":"L Almeida","year":"2021","unstructured":"Almeida, L. et al. Ribosome-targeting antibiotics impair T cell effector function and ameliorate autoimmunity by blocking mitochondrial protein synthesis. Immunity 54 (1), 68\u201383. https:\/\/doi.org\/10.1016\/j.immuni.2020.11.001 (2021).","journal-title":"Immunity"},{"issue":"4","key":"86951_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","volume":"38","author":"EL Pearce","year":"2013","unstructured":"Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity 38 (4), 633\u2013643. https:\/\/doi.org\/10.1016\/j.immuni.2013.04.005 (2013).","journal-title":"Immunity"},{"issue":"8","key":"86951_CR35","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1261\/rna.078776.121","volume":"27","author":"L Hamouche","year":"2021","unstructured":"Hamouche, L., Poljak, L. & Carpousis, A. J. Ribosomal RNA degradation induced by the bacterial RNA polymerase inhibitor rifampicin. Rna 27 (8), 946\u2013958. https:\/\/doi.org\/10.1261\/rna.078776.121 (2021).","journal-title":"Rna"},{"issue":"1","key":"86951_CR36","doi-asserted-by":"publisher","first-page":"2250575","DOI":"10.1080\/14756366.2023.2250575","volume":"38","author":"LR Hemeda","year":"2023","unstructured":"Hemeda, L. R. et al. Discovery of pyrimidine-tethered benzothiazole derivatives as novel anti-tubercular agents towards multi- and extensively drug resistant Mycobacterium tuberculosis. J. Enzyme Inhib. Med. Chem. 38 (1), 2250575. https:\/\/doi.org\/10.1080\/14756366.2023.2250575 (2023).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"5","key":"86951_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.medmal.2006.12.006","volume":"37","author":"K Aouam","year":"2007","unstructured":"Aouam, K. et al. Adverse effects of antitubercular drugs: epidemiology, mechanisms, and patient management. Med. Mal Infect. 37 (5), 253\u2013261. https:\/\/doi.org\/10.1016\/j.medmal.2006.12.006 (2007).","journal-title":"Med. Mal Infect."},{"key":"86951_CR38","doi-asserted-by":"publisher","unstructured":"Rankine-Wilson, L. I., Shapira, T., Emani, C. S. & Av-Gay, Y. From infection niche to therapeutic target: the intracellular lifestyle of Mycobacterium tuberculosis. Microbiol. (Reading). 167 (4). https:\/\/doi.org\/10.1099\/mic.0.001041 (2021).","DOI":"10.1099\/mic.0.001041"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86951-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86951-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86951-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T16:53:25Z","timestamp":1737737605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86951-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86951"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86951-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3137"}}